Myota Raises $4.5 Mn in Series A Round led by PeakBridge

The company will use the new funding to grow its B2B sales operations in the U.S. and Europe, expand its direct-to-consumer (D2C) business, and support more clinical research on its products.

Read Also- Novak Djokovic Joins General Atlantic as Global Strategic Advisor

Myota has developed patented prebiotic fiber blends that are designed to improve gut health by increasing the production of beneficial short-chain fatty acids while reducing digestive discomfort. These ingredients can be added to everyday food and drinks and have shown promising results in clinical studies.

“We can measure how an individual’s gut bacteria ferment different fibers, and we use that to build blends that produce short-chain fatty acids reliably across very different microbiomes,” said Thomas Gurry, co-founder and chief scientific officer of Myota. “Our randomized controlled trials have shown improvements in insulin sensitivity, blood sugar control, inflammation and mood including stress and anxiety. That evidence base is what separates a functional ingredient from a marketing claim.”

“Fiber is one of the most powerful and overlooked levers for human health, and for years the products on shelves haven’t done it justice,” said Kat Stennett, co-founder and CEO of Myota. “What’s been missing is fiber that works across real, varied microbiomes and stands up to clinical scrutiny. That is what we’ve built, and it’s why companies across F&B, food service, and wellness are coming to us to put genuine, claimable benefits into their products. This round lets us meet that demand at scale.”

“Most gut-health products are a marketing story built on one or two commodity fibers,” said Yoni Glickman, managing partner at PeakBridge. “Myota built and patented the science first and then validated the outcomes in clinical trials. We saw fiber becoming a pillar of modern nutrition five years ago, backed Myota early, and we’re proud to continue supporting their excellent team now.”

Founded by Dr Thomas Gurry, Myota is a health technology startup that develops prebiotic fibre blends and a digital health platform to support better gut health.

The company uses data and microbiome research to improve overall well-being and help reduce the risk of chronic diseases.